Status:

COMPLETED

Basal/Bolus Versus Sliding Scale Insulin In Hospitalized Patients With Type 2 Diabetes

Lead Sponsor:

Emory University

Collaborating Sponsors:

Sanofi

University of Miami

Conditions:

Diabetes

Hyperglycemia

Eligibility:

FEMALE

18-70 years

Phase:

PHASE4

Brief Summary

High blood glucose levels in hospitalized patients with diabetes are associated with increased risk of medical complications. Improved glucose control with insulin injections may improve clinical outc...

Detailed Description

This study will compare how well regular insulin will compare to glargine (Lantus®) once daily plus glulisine (Apidra®) insulin before meals in hospitalized patients with type 2 diabetes and elevated ...

Eligibility Criteria

Inclusion

  • Males or females between the ages of 18 and 70 years admitted to a general medicine service.
  • A known history of type 2 diabetes mellitus \> 3 months, receiving either diet alone or any combination of oral antidiabetic agents (sulfonylureas, metformin, thiazolidinediones).
  • Subjects must have an admission blood glucose \> 140 mg and \< 400 mg/dL without laboratory evidence of diabetic ketoacidosis (serum bicarbonate \< 18 mEq/L or positive serum or urinary ketones).

Exclusion

  • Subjects with increased blood glucose concentration, but without a known history of diabetes.
  • Subjects with a history of diabetic ketoacidosis and hyperosmolar hyperglycemic state, or ketonuria \[57\].
  • Patients with known HIV, acute critical or surgical illness and/or expected to require admission to a critical care unit (ICU, CCU), corticosteroid therapy, or to undergo surgery during the hospitalization course.
  • Patients with clinically relevant hepatic disease or impaired renal function, as shown by a serum creatinine ≥3.0.
  • Mental condition rendering the subject unable to understand the nature, scope, and possible consequences of the study.
  • Patients with recognized or suspected endocrine disorders associated with increased insulin resistance, acromegaly, or hyperthyroidism.
  • Female subjects are pregnant or breast feeding at time of enrollment into the study.

Key Trial Info

Start Date :

September 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2006

Estimated Enrollment :

130 Patients enrolled

Trial Details

Trial ID

NCT00394407

Start Date

September 1 2005

End Date

June 1 2006

Last Update

November 21 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Miami School of Medicine

Coral Gables, Florida, United States, 33124